Dyne Therapeutics, Inc. (DYN)
NASDAQ: DYN · Real-Time Price · USD
15.38
+0.10 (0.65%)
At close: Feb 18, 2026, 4:00 PM EST
15.38
0.00 (0.00%)
After-hours: Feb 18, 2026, 4:00 PM EST
Dyne Therapeutics Market Cap
Dyne Therapeutics has a market cap or net worth of $2.54 billion as of February 18, 2026. Its market cap has increased by 75.22% in one year.
Market Cap
2.54B
Enterprise Value
1.86B
1-Year Change
75.22%
Ranking
Category
Stock Price
$15.38
Market Cap Chart
Since the IPO on September 17, 2020, Dyne Therapeutics's market cap has increased from $790.90M to $2.54B, an increase of 220.60%. That is a compound annual growth rate of 23.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 17, 2026 | 2.52B | -21.88% |
| Dec 31, 2025 | 3.22B | 34.33% |
| Dec 31, 2024 | 2.40B | 193.72% |
| Dec 29, 2023 | 816.30M | 35.12% |
| Dec 30, 2022 | 604.12M | -0.31% |
| Dec 31, 2021 | 606.03M | -36.50% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 17, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Spyre Therapeutics | 2.84B |
| Beam Therapeutics | 2.76B |
| Apellis Pharmaceuticals | 2.75B |
| Viridian Therapeutics | 2.66B |
| IDEAYA Biosciences | 2.65B |
| Tarsus Pharmaceuticals | 2.58B |
| Travere Therapeutics | 2.49B |
| Adaptive Biotechnologies | 2.47B |